Focus: Perimeter Medical Imaging AI is a Toronto-based biotechnology company specializing in AI-enabled surgical imaging solutions for cancer margin identification during oncologic procedures. The company operates at the intersection of medical devices, AI, and surgical oncology with a focused market niche.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Stable — net -1 jobs in 30d
1 added, 2 removed. Backfill posture.
Best suited for early-career professionals or those seeking startup equity upside in surgical AI; higher risk tolerance required due to pre-revenue status and limited transparency.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Perimeter Medical Imaging AI
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Perimeter Medical Imaging AI's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles